Skip to content
BOLUS

Signal from the log

Forus

150 M$ · Series C · United States · Health software

Forus fait circuler les ordonnances entre médecins, pharmacies, assureurs et laboratoires par des agents logiciels qui prennent en charge l'accord préalable et l'aide financière au patient. Fondée en 2023, la société dit couvrir des prescripteurs dans les cinquante États américains.

Verified

Announced on , logged by the watch of 8 September 2026.

Operation
Funding round
Announced amount
150 M$
Stage
Series C
Country
United States
Sector
Health software

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Bain Capital Ventures , with Thrive Capital , General Catalyst , Accel , Redpoint , BoxGroup , Pear VC

Provenance
Logged on 8 September 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).